Revenue management systems: Unlocking the power of offering, pricing, and quoting in medtech and diagnostics

Published on December 4, 2024

img { width:100%; }

In March, we initiated our new insights series called "Embracing end-to-end revenue management in medtech and diagnostics." Our introductory blog discussed the importance of Revenue Management Systems (RMS) for medtech and diagnostics companies aiming to adapt to economic fluctuations and achieve commercial excellence. The next article in the series shed…

header

Continue reading on website
Other news

Adapting to private label competition: Building a resilient brand

December 3, 2024
Private labels are steadily gaining ground, and this growth presents both challenges and opportunities for brand manufacturers. As retailers expand their private label offerings, often at competitive price points, brands may experience increased pressure on margins and heightened competition for shelf space. However, this evolution also offers unique opportunities for brands to stand out by emphas

Driving P&MA success in the US pharma and biotech market: A guide to business agility

December 5, 2024
hr { border-color: #c80041;}.table-container1 { margin: 0 auto; max-width: 1000px; overflow: visible;}.table-container1, .table-container2 { width: 100%;}.table-container1 img {max-width: 50px !important;}.table-container1 table { width: 100%; border-collapse: collapse; margin-top: 20px; background: #fff; border: 1px solid #ccc; table-layout: fixed;}.table-container1 thead { backgroun